Mutant Oncogenes. Targets for Therapy
1992
Mutant Oncogenes: Targets for Therapy
publication
Author Information
Author(s): N. Lemoine, A. Epenetos
Conclusion
The book presents promising potential for oncogenes and their products as targets for specific cancer therapies.
Supporting Evidence
- Many papers in the book highlight the potential of oncogenes as therapy targets.
- Monoclonal antibodies against c-erbB-2 show promise in treating cancers with this receptor.
- Strategies involving antibodies to c-erbB-2 coupled with toxins are discussed.
- The book provides an overview of ras oncogenes and their clinical potentials.
- Potential strategies for reverting ras transformation are outlined.
Takeaway
This book talks about how certain genes can be used to help treat cancer, which is really exciting!
Limitations
Some papers only describe findings without focusing on therapy targets, and the coverage of tumor suppressor genes is limited.
Want to read the original?
Access the complete publication on the publisher's website